Avastin

The Chemotherapy Clinical Reference Group ( CRG ) has reviewed drugs and drug indications for inclusion on the National cancer...


A single-practice retrospective chart review has reported on long-term visual outcomes in patients receiving continuous fixed-interval dosing of anti-vascular endothelial...


The European Commission ( EU ) has approved the use of Avastin ( Bevacizumab ) in combination with Paclitaxel, Topotecan,...


Bevacizumab ( Avastin ), a monoclonal antibody that targets VEGF, has shown restricted activity in patients with advanced melanoma. A...


Standard therapy for newly diagnosed glioblastoma is radiotherapy plus Temozolomide ( Temodal ). In this phase 3 study, researchers have...


Prolonging first-line chemotherapy results with maintenance treatment may influence overall survival. In HER2-negative patients with locally recurrent/metastatic breast cancer, combining...


Combining Bevacizumab ( Avastin ) with first- or second-line chemotherapy in randomised phase III trials showed significantly improved progression-free survival...


Glioblastoma ( GBM ) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years,...


Preclinical data suggest that triple-negative breast cancers are sensitive to interstrand crosslinking agents, and that synergy may exist for the...


Roche has announced that the EU Committee for Medicinal Products for Human Use ( CHMP ) has recommended that the...


Bevacizumab ( Avastin ), a monoclonal antibody that targets VEGF, has shown restricted activity in patients with advanced melanoma. A...


Interim analysis of a large, randomized clinical trial has shown that patients with advanced, recurrent, or persistent cervical cancer that...


Glioblastoma is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the average...


The aim of the GEFAL trial was to evaluate the relative efficacy and safety profile of Bevacizumab ( Avastin )...


The FIRE-3 study has compared the two epidermal growth factor receptor ( EGFR ) antibodies, on top of chemotherapy, in...


In patients with KRAS, wild-type metastatic colorectal cancer ( mCRC ) a head to head comparison of anti-EGFR- and anti-VEGF-directed...


The FDA ( Food and Drug Administration ) has approved a new use of Avastin ( Bevacizumab ) in combination...


PAVES ( Pegfilgrastim and Anti-VEGF Evaluation Study ) trial has evaluated Pegfilgrastim ( Neulasta ) in 845 patients receiving FOLFOX...


The results from PAVES ( Pegfilgrastim and Anti-VEGF Evaluation Study ), a Phase 3 trial which evaluated Neulasta ( Pegfilgrastim...


Cancer patients treated with Bevacizumab ( Avastin ) in combination with chemotherapy are at significantly greater risk of potentially life-threatening...